首页|酮咯酸氨丁三醇注射液联合枸橼酸舒芬太尼注射液在全膝关节置换术后患者静脉自控镇痛中的应用效果

酮咯酸氨丁三醇注射液联合枸橼酸舒芬太尼注射液在全膝关节置换术后患者静脉自控镇痛中的应用效果

扫码查看
目的:观察酮咯酸氨丁三醇注射液联合枸橼酸舒芬太尼注射液在全膝关节置换术后患者静脉自控镇痛中的应用效果.方法:选取2020年1月至2022年1月该院收治的120例全膝关节置换术后患者进行前瞻性研究,按照随机数字表法将其分为观察组(n=60)和对照组(n=60).两组术后均行静脉自控镇痛,对照组用药为枸橼酸舒芬太尼注射液,观察组用药为酮咯酸氨丁三醇注射液联合枸橼酸舒芬太尼注射液,比较两组疼痛视觉模拟评分法(VAS)评分、血清炎性因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、超敏C反应蛋白(hs-CRP)]水平、简易精神状态量表(MMSE)评分和不良反应发生率.结果:术后 2、4、8、24、48 h,两组静息与活动(咳嗽)状态下VAS评分组间比较,差异均无统计学意义(P>0.05);术后 24 h,两组血清IL-6、hs-CRP、TNF-α水平高于术前,但观察组低于对照组,差异均有统计学意义(P<0.05);术后 4、8 h,观察组MMSE评分均高于对照组,差异有统计学意义(P<0.05);术后 48 h,观察组不良反应发生率为 21.67%,低于对照组的 43.33%,差异有统计学意义(P<0.05).结论:酮咯酸氨丁三醇注射液联合枸橼酸舒芬太尼注射液用于全膝关节置换术后患者静脉自控镇痛可提高其MMSE评分,降低其不良反应发生率和炎性因子水平,效果优于单纯枸橼酸舒芬太尼注射液静脉自控镇痛.
Effects of Ketorolac tromethamine injection combined with Sufentanil citrate injection on patient-controlled intravenous analgesia after total knee arthroplasty
Objective:To observe effects of Ketorolac tromethamine injection combined with Sufentanil citrate injection on patient-controlled intravenous analgesia after total knee arthroplasty.Methods:A prospective study was conducted on 120 patients after total knee arthroplasty admitted to the hospital from January 2020 to January 2022.According to the random number table method,they were divided into observation group(n=60)and control group(n=60).The postoperative patient-controlled intravenous analgesia was performed in both groups.The control group was treated with Sufentanil citrate injection,while the observation group was treated with Ketorolac tromethamine injection combined with Sufentanil citrate injection.The pain visual analogue scale(VAS)score,the serum inflammatory factors[interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),high-sensitivity C-reactive protein(hs-CRP)]levels,the mini-mental state examination scale(MMSE)score,and the incidence of adverse reactions were compared between the two groups.Results:2,4,8,24 and 48 h after the surgery,there were no significant differences in the VAS scores between the two group in resting state and active(cough)state(P>0.05).24 h after the surgery,the levels of serum IL-6,hs-CRP and TNF-α in the two groups were higher than those before the surgery,but those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).4 and 8 h after the surgery,the MMSE scores of the observation group were higher than those of the control group,and the differences were statistically significant(P<0.05).Further,48 h after the surgery,the incidence of adverse reactions in the observation group was 21.67%,which was lower than 43.33%in the control group,and the difference was statistically significant(P<0.05).Conclusions:Ketorolac tromethamine injection combined with Sufentanil citrate injection for patient-controlled intravenous analgesia after total knee arthroplasty can improve the MMSE scores,reduce the incidence of adverse reactions and the inflammatory factor levels.Moreover,it is superior to Sufentanil citrate injection intravenous patient-controlled analgesia.

Total knee arthroplastyPostoperativePatient-controlled intravenous analgesiaKetorolac tromethamineSufentanil citrateMMSE scoreInflammatory factor

颜惠敏、谈金凤

展开 >

苏州明基医院药剂科,江苏 苏州 215000

全膝关节置换术 术后 静脉自控镇痛 酮咯酸氨丁三醇 枸橼酸舒芬太尼 MMSE评分 炎性因子

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(6)
  • 8